CATALYST DOSSIER · UPDATED 2026-11-10
$ABCL
Unclassified · convergence — · conviction —
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $ABCL?
Quantitative
Net Income (CY2026Q2) : $-55.4M (-59.6% YoY)
Catalysts
Multi-spoke convergence : 5 convergent signals fired: biotech, auto_setup_classifier, auto_macro_edgar_fts, auto_macro_ofac_sanctions, auto_macro_options_gex
Risks
Position-sizing discipline : Conviction AVOID (-12 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
AEI via real_estate r=+0.95 sympathetic (score 6)
OPEN via real_estate r=+0.95 sympathetic (score 3)
NFE via utilities r=+0.94 sympathetic (score 50)
EVRG via utilities r=+0.94 sympathetic (score 17)
GPI via consumer r=+0.90 sympathetic (score 28)
NXXT via consumer r=+0.90 sympathetic (score 24)
Signals Firing
No active signals this cycle.
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.